Anacor Pharmaceuticals (ANAC)

Add to Watchlists Create an Alert
5.47 -0.02  -0.36%   NASDAQ May 23, 8:00PM BATS Real time Currency in USD

Anacor Pharmaceuticals Revenue Quarterly YoY Growth:

26.66% for Dec. 31, 2012
View Full Chart

Anacor Pharmaceuticals Revenue Quarterly YoY Growth Chart

    Anacor Pharmaceuticals Historical Revenue Quarterly YoY Growth Data

    Pro Data Export
    Dates:  to
    Viewing 1 of 1   First  Previous First    Next  Last   Last

    There is no data for the selected date range.

    Data for this Date Range  
    Dec. 31, 2012 26.66%
    Sept. 30, 2012 -80.44%
    June 30, 2012 -10.33%
    March 31, 2012 9.42%
    Dec. 31, 2011 -26.73%
    Sept. 30, 2011 -25.17%
    June 30, 2011 -57.19%
    March 31, 2011 211.1%
       
    Dec. 31, 2010 -47.70%
    Sept. 30, 2010 1938%
    June 30, 2010
    March 31, 2010
    Dec. 31, 2009
    Sept. 30, 2009
    Dec. 31, 2007 Go Pro
    Sept. 30, 2007 Go Pro

    About Revenue Growth

    Revenue growth illustrates sales increases/decreases over time. It is used to measure how fast a business is expanding. More valuable than a snapshot of revenue, revenue growth helps investors identify trends in order to gauge revenue growth over time.

    If a company generated $75 billion in revenue during 2008 and $100 billion in revenue during 2009, the company experienced roughly a ($100 billion/$75 billion)-1 = %33 increase in revenue.
    Learn More

    Get data for

    ANAC Revenue Quarterly YoY Growth Benchmarks

    Companies
    Valeant Pharmaceuticals International 24.79%
    QLT
    Santarus 73.15%

    ANAC Revenue Quarterly YoY Growth Rankings

    Overall 90th percentile
    750 of 8006
    Sector 82nd percentile
    119 of 686 in Healthcare
    Industry 79th percentile
    51 of 248 in Biotechnology

    ANAC Revenue Quarterly YoY Growth Range, Past 5 Years

    Minimum -80.44% Sep 2012
    Maximum 1938% Sep 2010
    Average 193.8%